3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Neuroblastoma
8
Prostatic Neoplasms
3
Skin Neoplasms
2
Sarcoma, Ewing
2
Precancerous Conditions
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive
2
Medulloblastoma
2
Glioma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Typical Teratoid Rhabdoid Tumor
1
Stomach Neoplasms
1
Rhabdoid Tumor
1
Osteosarcoma Recurrent
1
Oligodendroglioma
1
Non-melanoma Skin Cancer
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Keratosis, Actinic
1
Glioblastoma
1
Gastritis, Atrophic
1
Esophageal Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Non-Small-Cell Lung
1
Astrocytoma
1
Interventions
Eflornithine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Osteosarcoma Recurrent
×
Eflornithine
×
Clear all
NCT06892678
2026-05-14
DFMO
Montefiore Medical Center
Phase 1/2
Recruiting
15 enrolled